Yes, plaques can serve as biomarkers for exposure to toxicants and the associated risk of disease. For instance, the presence of amyloid plaques in cerebrospinal fluid can indicate early-stage Alzheimer's disease, potentially linked to neurotoxic exposure. Similarly, imaging techniques can detect atherosclerotic plaques, providing insights into cardiovascular health and possible environmental influences.
